High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 11, 2012, Pages 5811-5820

  Fouhy, Fiona ^a,b   Guinane, Caitriona M ^a,c   Hussey, Seamus ^b,d   Wall, Rebecca ^a,c   Ryan, C Anthony ^b   Dempsey, Eugene M ^b,e   Murphy, Brendan ^b   Ross, R Paul ^a,c   Fitzgerald, Gerald F ^b,c   Stanton, Catherine ^a,c   Cotter, Paul D ^a,c  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e Irish Centre for Fetal and Neonatal Translational Research   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; GENTAMICIN; RNA 16S; RNA POLYMERASE BETA SUBUNIT;

ACTINOBACTERIA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIFIDOBACTERIUM; BIRTH; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CONVALESCENCE; DIARRHEA; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENE TARGETING; HIGH THROUGHPUT SEQUENCING; HUMAN; INFANT; INTESTINE FLORA; INTESTINE INFECTION; LACTOBACILLUS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEOBACTERIA; PYROSEQUENCING; QUANTITATIVE ANALYSIS; TREATMENT DURATION;

ACTINOBACTERIA; AMPICILLIN; ANTI-BACTERIAL AGENTS; BIFIDOBACTERIUM; COLONY COUNT, MICROBIAL; DNA PRIMERS; FECES; FEMALE; GASTROINTESTINAL TRACT; GENTAMICINS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFANT; INFUSIONS, PARENTERAL; LACTOBACILLUS; MALE; METAGENOME; POLYMERASE CHAIN REACTION; PROTEOBACTERIA; RECOVERY OF FUNCTION; RNA, RIBOSOMAL, 16S;

EID: 84868036621     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00789-12     Document Type: Article

References (74)

1. Abrahamsson TR, et al. 2011. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol. 129:434-440.
2. Acred P, Brown D, Turner D, Wilson M. 1962. Pharmacology and chemotherapy of ampicillin - a new broad-spectrum penicillin. Br. J. Pharmacol. Chemother. 18:356-369.
3. Adlerberth I, Wold AE. 2009. Establishment of the gut microbiota in Western infants. Acta Pædiatr. 98:229-238.
4. Ajslev T, Andersen C, Gamborg M, Sørensen T, Jess T. 2011. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, prepregnancy weight and early administration of antibiotics. Int. J. Obesity 35:522-529.
5. Altschul SF, et al. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
6. Antonopoulos DA, et al. 2009. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 77:2367-2375.
7. Bennet R, Eriksson M, Nord CE. 2002. The fecal microflora of 1-3-month-old infants during treatment with eight oral antibiotics. Infection 30:158-160.
8. Bezirtzoglou E, Tsiotsias A, Welling GW. 2011. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 17:478-482.
9. Blaser M. 2011. Antibiotic overuse: stop the killing of beneficial bacteria. Nature 476:393-394.
10. Boehm G, et al. 2005. Prebiotic carbohydrates in human milk and formulas. Acta Paediatr. 94:18-21.
11. Bourlioux P, Koletzko B, Guarner F, Braesco V. 2003. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am. J. Clin. Nutr. 78:675-683.
12. Bush K. 2010. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 13:558-564.
13. Celedon JC, Fuhlbrigge A, Rifas Shiman S, Weiss ST, Finkelstein JA. 2004. Antibiotic use in the first year of life and asthma in early childhood. Clin. Exp. Allergy 34:1011-1016.
14. Cramer JP, Burchard GD, Lohse AW. 2008. Old dogmas and new perspectives in antibiotic-associated diarrhea. Med. Klinik. (Munich) 103: 325-338.
15. Cremonini F, et al. 2002. Meta analysis: the effect of probiotic administration on antibiotic associated diarrhoea. Aliment. Pharmacol. Ther. 16: 1461-1467.
16. De La Cochetiere M, et al. 2005. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J. Clin. Microbiol. 43: 5588-5592.
17. Dethlefsen L, Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:e280. doi:210.137/journal.pbio.0060280.
18. Dethlefsen L, Relman DA. 2011. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. U. S. A. 108:4554-4561.
19. Dominguez-Bello MG, et al. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U. S. A. 107:11971-11976.
20. Donabedian S, et al. 2003. Molecular characterization of gentamicin-resistant enterococciin the United States: evidence of spread from animals to humans through food. J. Clin. Microbiol. 41:1109-1113.
21. Echarri PP, et al. 2011. Assessment of intestinal microbiota of full-term breastfed infants from two different geographical locations. Early Hum. Dev. 87:511-513.
22. Fallani M, et al. 2010. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J. Pediatr. Gastroenterol. Nutr. 51:77-84.
23. Favier CF, de Vos WM, Akkermans ADL. 2003. Development of bacterial and bifidobacterial communitiesinfecesofnewborn babies. Anaerobe 9:219-229.
24. Finegold SM. 1970. Interaction of antimicrobial therapy and intestinal flora. Am. J. Clin. Nutr. 23:1466-1471.
25. Foliaki S, et al. 2009. Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: international study of asthma and allergies in childhood phase III. J. Allergy Clin. Immunol. 124:982-989.
26. Fouhy F, Ross RP, Fitzgerald G, Stanton C, Cotter PD. 2012. Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes 3:203-220.
27. Fujimura KE, Slusher NA, Cabana MD, Lynch SV. 2010. Role of the gut microbiota in defining human health. Expert Rev. Anti-infect. Ther. 8:435-454.
28. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJO. 2006. Differences between tissue-associated intestinal micro-floras of patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 44:4136-4141.
29. Grölund MM, Lehtonen OP, Eerola E, Kero P. 1999. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J. Pediatr. Gastroenterol. Nutr. 28:19-25.
30. Guarner F, Malagelada JR. 2003. Gut flora in health and disease. Lancet 361:512-519.
31. Haarman M, Knol J. 2005. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Applied Environ. Microbiol. 71:2318-2324.
32. Hill DA, Artis D. 2010. Intestinal bacteria and the regulation of immune cell homeostasis. Annu. Rev. Immunol. 28:623-667.
33. Hill DA, et al. 2010. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 3:148-158.
34. Huson DH, Auch AF, Qi J, Schuster SC. 2007. MEGAN analysis of metagenomic data. Genome Res. 17:377-386.
35. Hussey S, et al. 2011. Parenteral antibiotics reduce bifidobacteria colonization and diversity in neonates. Int. J. Microbiol. 2011:130574. doi: 10.1155/2011/130574.
36. Huycke M, Spiegel C, Gilmore M. 1991. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 35:1626-1634.
37. Ivanov II, et al. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337-349.
38. Jakobsson HE, et al. 2010. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 5:e9836. doi:9810.1371/journal.pone.0009836.
39. Jernberg C, Löfmark S, Edlund C, Jansson JK. 2010. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156:3216-3223.
40. Johnson CC, et al. 2005. Antibiotic exposure in early infancy and risk for childhood atopy. J. Allergy Clin. Immunol. 115:1218-1224.
41. Jureen R, et al. 2003. Molecular characterization of ampicillin-resistant Enterococcus faecium isolates from hospitalized patients in Norway. J. Clin. Microbiol. 41:2330-2336.
42. Kassinen A, et al. 2007. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133:24-33.
43. Kim BJ, Kim HY, Yun YJ, Kook YH. 2010. Differentiation of Bifidobacterium species using partial RNA polymerase β-subunit (rpoB) gene sequences. Int. J. Syst. Evol. Microbiol. 60:2697-2704.
44. Kozyrskyj AL, Ernst P, Becker AB. 2007. Increased risk of childhood asthma from antibiotic use in early life. Chest 131:1753-1759.
45. Le Huërou-Luron I, Blat S, Boudry G. 2010. Breast-v. formula-feeding: impacts on the digestive tract and immediate and long-term health effects. Nutr. Res. Rev. 23:23-36.
46. Ley RE. 2010. Obesity and the human microbiome. Curr. Opin. Gastroenterol. 26:5-11.
47. Mai V, Draganov PV. 2009. Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J. Gastroenterol. 15:81-85.
48. Mangin I, Suau A, Gotteland M, Brunser O, Pochart P. 2010. Amoxicillin treatment modifies the composition of Bifidobacterium species in infant intestinal microbiota. Anaerobe 16:433-438.
49. Matsuki T, et al. 2004. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl. Environ. Microbiol. 70:167-173.
50. Mättö J, et al. 2007. Susceptibility of human and probiotic Bifidobacterium spp. to selected antibiotics as determined by the Etest method. Int. Dairy J. 17:1123-1131.
51. Murphy E, et al. 2010. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59:1635-1642.
52. Nordmann P. 1998. Trends in β-lactam resistance among Enterobacteri-aceae. Clin. Infect. Dis. 27:S100-S106.
53. Olszak T, et al. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336:489-493.
54. O'Sullivan Ó, et al. 2011. Correlation of rRNA gene amplicon pyro-sequencing and bacterial culture for microbial compositional analysis of faecal samples from elderly Irish subjects. J. Appl. Microbiol. 111:467-473.
55. Parracho H, McCartney AL, Gibson GR. 2007. Probiotics and prebiotics in infant nutrition. Proc. Nutr. Soc. 66:405-411.
56. Penders J, et al. 2006. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511-521.
57. Qin X, et al. 2009. Prevalence and mechanisms of broad-spectrum β-lactam resistance in Enterobacteriaceae: a children's hospital experience. Anti-microb. Agents Chemother. 53:3909-3914.
58. Rea MC, et al. 2011. Effect of broad-and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc. Natl. Acad. Sci. U. S. A. 108:4639-4645.
59. Robinson CJ, Young VB. 2010. Antibiotic administration alters the community structure of the gastrointestinal microbiota. Gut Microbes 1:279-284.
60. Sazawal S, et al. 2010. Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial. PLoS One 5:e12164. doi:10.1371/journal.pone. 0012164.
61. Schloss P, Handelsman J. 2008. A statistical toolbox for metagenomics: assessing functional diversity in microbial communities. BMC Bioinformatics 9:34-49.
62. Schloss PD, et al. 2009. Introducing MOTHUR: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75:7537-7541.
63. Schwiertz A, Gruhl B, Löbnitz M, Michel P. 2003. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr. Res. 54:393-399.
64. Sekirov I, Russell SL, Antunes LCM, Finlay BB. 2010. Gut microbiota in health and disease. Physiol. Rev. 90:859-904.
65. Sherman PM, et al. 2009. Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27-28, 2008. J. Pediatr. 155:S61-S70.
66. Suchodolski J, et al. 2009. The effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing. BMC Microbiol. 9:210-226.
67. Sullivan Å, Edlund C, Nord CE. 2001. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 1:101-114.
68. Tanaka S, et al. 2009. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol. Med. Microbiol. 56:80-87.
69. Turnbaugh PJ, Gordon JI. 2009. The core gut microbiome, energy balance and obesity. J. Physiol. 587:4153-4158.
70. Urich T, et al. 2008. Simultaneous assessment of soil microbial community structure and function through analysis of the meta-transcriptome. PLoS One 3:e2527. doi:2510.1371/journal.pone.0002527.
71. Weisser M, et al. 2012. Dynamics of ampicillin-resistant Enterococcus faecium clones colonizing hospitalized patients: data from a prospective observational study. BMC Infect. Dis. 12:68-77.
72. Westerbeek EAM, et al. 2006. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin. Nutr. 25:361-368.
73. Zhang H, et al. 2009. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. U. S. A. 106:2365-2370.
74. Zoetendal E, Rajilic-Stojanovic M, De Vos W. 2008. High-throughput diversity and functionality analysis of the gastrointestinal tract micro-biota. Gut 57:1605-1615.